RF21| PSUN08 Morphologic or Molecular Imaging-Diagnostic Capabilities in von Hippel-Lindau related pheochromocytoma

Mayank Patel , Abhisek Jha , Alexander Ling , Clara C Chen
Journal of the Endocrine Society 6 ( Suppl 1) A139 -A139

2022
Effects of amino acid co-infusion on increased catecholamine symptoms in metastatic pheochromocytoma patients treated with 177Lu-DOTATATE

Karel Pacak , Jorge Carrasquillo , Philip Eclarinal , Maria Liza Lindenberg
The Journal of Nuclear Medicine 60 76 -76

2019
2020
Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma.

Karel Pacak , Jorge Amilcar Carrasquillo , Joanna Klubo-Gwiezdzinska , Baris Turkbey
Frontiers in Endocrinology 11 587065 -587065

2021
Developmental vascular malformations in EPAS1 gain-of-function syndrome.

Karel Pacak , Alexander Vortmeyer , Dorian B McGavern , Panagiotis Mastorakos
JCI insight 6 ( 5) 144368

2021
High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.

Karel Pacak , Jorge A. Carrasquillo , Andrei H. Iagaru , Wouter W. de Herder
Clinical Cancer Research 27 ( 11) 2989 -2995

31
2021
Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World.

Karel Pacak , David Taieb , Isabel Tena , Abhishek Jha
Frontiers in Endocrinology 12 625312 -625312

2021
A case of Carney triad complicated by renal cell carcinoma and a germline SDHA pathogenic variant.

Karel Pacak , Constantine A Stratakis , Martha M Quezado , Paraskevi Xekouki
Endocrinology, Diabetes & Metabolism Case Reports 2021 ( 1)

2021
Lutetium-177 DOTATATE Therapy Is Associated With Biochemical Endocrine Abnormalities in the Immediate Post-Treatment Period

Karel Pacak , Jorge A Carrasquillo , Joanna Klubo-Gwiezdzinska , Baris Turkbey
Journal of the Endocrine Society 5

2021
Neuraxial dysraphism in EPAS1-associated syndrome due to improper mesenchymal transition

Jared S. Rosenblum , Anthony J. Cappadona , Davis P. Argersinger , Ying Pang
Neurology Genetics 6 ( 3) e414

4
2020
Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation

Zahraa Abdul Sater , Abhishek Jha , Ahmed Hamimi , Adel Mandl
The Journal of Clinical Endocrinology and Metabolism 105 ( 4) 1176 -1185

3
2020
Prospective evaluation of 68Ga‐DOTATATE PET/CT in limited disease neuroendocrine tumours and/or elevated serum neuroendocrine biomarkers

Sophie Gabriel , Philippe Garrigue , Laetitia Dahan , Frédéric Castinetti
Clinical Endocrinology 89 ( 2) 155 -163

8
2018
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma

Maran Ilanchezhian , Abhishek Jha , Karel Pacak , Jaydira Del Rivero
Current Treatment Options in Oncology 21 ( 11) 85

3
2020
OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign?

Zahraa Abdul Sater , Abhishek Jha , Ahmed Hamimi , Adel Mandl
Journal of the Endocrine Society 3

2019
SAT-310 18F-FDOPA PET/CT Accurately Identifies Pheochromocytoma in 70-Year-Old Male with MEN1

Aisha Tepede , James Welch , Adel Mandl , Sunita Agarwal
Journal of the Endocrine Society 3

2019
Eruption of Metastatic Paraganglioma After Successful Therapy with 177 Lu/ 90 Y-DOTATOC and 177 Lu-DOTATATE

Katherine I. Wolf , Abhishek Jha , Anouk van Berkel , Damian Wild
Nuclear Medicine and Molecular Imaging 53 ( 3) 223 -230

4
2019
Gallbladder Paraganglioma Associated with SDHD Mutation: a Potential Pitfall on 18 F-FDOPA PET Imaging

Zahraa Abdul Sater , Abhishek Jha , Adel Mandl , Sheila K. Mangelen
Nuclear Medicine and Molecular Imaging 53 ( 2) 144 -147

2
2019